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Abstract
Background: Toll-like receptors (TLRs) recognize known molecules from microbes and have an established role in
tumorigenesis. Using a rat model of esophageal adenocarcinoma, and human clinical samples, we investigated
genes central to TLR-mediated signal transduction and characterized the esophageal microbiome across the
spectrum of esophageal adenocarcinoma carcinogenesis.
Methods: We surgically induced bile/acid reflux in rats and their esophagi were harvested at 40 weeks post-surgery.
Tissue samples from the model were selected for gene expression profiling. Additionally, for rat and human samples
microbiome analysis was performed using PCR-ESI-MS-TOF technology with validation by fluorescence in situ
hybridization.
Results: Gene expression results in the rat model indicated a significant upregulation of TLRs 1-3, 6, 7 and 9 in EAC
compared to normal epithelium. PCR-ESI-MS-TOF analysis revealed a prevalence of Escherichia coli in Barrett’s
esophagus (60 %) and esophageal adenocarcinoma (100 %), which was validated by fluorescence in situ hybridization.
In the human clinical samples, Streptococcus pneumonia was detected in high abundance in gastroesophageal reflux
disease and Barrett’s esophagus (50–70 %) in comparison to tumor adjacent normal epithelium, dysplasia, and
esophageal adenocarcinoma (20–30 %). E. coli was detected in the Barrett’s esophagus and esophageal
adenocarcinoma groups but was absent in the tumor adjacent normal epithelium, dysplasia, and the
gastroesophageal reflux disease groups.
Conclusions: We demonstrated an association between the TLR signaling pathway and E. coli hinting towards
possible early molecular changes being mediated by microbes in the rat model of esophageal adenocarcinoma
carcinogenesis. Studies on human clinical samples also corroborate results to some extent; however, a study with
larger sample size is needed to further explore this association.
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Background
The incidence of esophageal adenocarcinoma (EAC) has
been on the rise over the past several decades [1]. Despite
some advances in the understanding of its pathogenesis
and treatment modalities, the 5 year survival for locally
advanced EAC is still dismal (less than 25 %) [2].
Barrett’s esophagus (BE) is the established precursor to
EAC that progresses through a metaplasia-dysplasia-
carcinoma sequence. BE is characterized by replacement
of normal stratified squamous epithelium by more
intestinal-like, simple columnar epithelium containing
goblet cells. It is postulated that conversion to a more
intestinal-like epithelium is an attempt to provide protec-
tion from acid and bile induced tissue damage in the
esophagus. Intestinal epithelial cells (IECs) provide this
protection in the gut by allowing colonization of the intes-
tinal tract by commensal bacteria which aid in digestion.
This markedly influences the development and function
of the mucosal immune system [3].
Recently, several studies demonstrate the importance of
specifically the innate microbial recognition by immune
and nonimmune cells in the gut. Paradoxically, either
diminished or exacerbated innate immune signaling may
trigger the breakdown of intestinal homeostasis, leading
possibly to disease [4]. This link between bacterial signal-
ing and innate immune host response has now been dem-
onstrated for several gastrointestinal (GI) malignancies
including esophageal cancer [5–11].
Given these findings, there has been an increased
interest in the role of innate immunity in tumorigen-
esis and the need for identifying new potential targets
[12]. Within this domain comes the role of toll-like
receptors (TLRs). TLRs constitute a family of highly
conserved, pattern-recognition receptors that
recognize known molecules from microbes as
pathogen-associated molecular patterns (PAMPs) or
danger-associated molecular patterns (DAMPs) that
are endogenous molecules released from necrotic or
dying cells [13–16]. Different TLRs serve as receptors
for diverse ligands including bacterial cell wall com-
ponents, viral double-stranded RNA, small-molecule
antiviral or immunomodulatory compounds [17], fla-
gellin and bacterial DNA. Since TLRs connect innate
and adaptive immune responses, they represent a sig-
nificant and potentially linking element between in-
flammation and cancer [18].
The goal of our present study was to evaluate the
potential links between microbial signaling, host
response and EAC progression by characterizing the
rat esophageal microbiome and focusing on profiling
the expression of genes central to TLR-mediated
signal transduction in a rat reflux model. Additionally,




The Institutional Animal Care and Use Committee
(IACUC) at Allegheny Health Network approved the
respective animal study protocols, all animals used in
this study were cared for, and all procedures were in
compliance with the “Guide for the Care and Use of
Laboratory Animals”. All animals were euthanized by
carbon dioxide inhalation.
Additionally, human samples were obtained under
written consent and the study was conducted in accord-
ance with the Declaration of Helsinki. The study was ap-
proved by the Internal Review Board (IRB) at Allegheny
Health Network under IRB Protocol 14-048 and the
assigned IRB Protocol number for written consent was
12-036.
Experimental design
Study schema outlining the major steps in the experi-
mental design is represented in Fig. 1.
Levrat model
The Levrat model was used to create a surgical end-to-side
esophagojejunal anastomosis in 6–8 week-old, 300 g male
Sprague-Dawley rats (Harlan Laboratories, Indianapolis,
IN) as previously described [19]. The animals were closely
monitored post-operatively and weighed weekly. Control
animals (no surgery) were included in the study. All
animals were euthanized at 40 weeks post-operatively
by carbon dioxide inhalation. If rats experienced a
25 % or greater weight loss after immediate postoper-
ative period or fit alternate euthanasia criteria, they
were sacrificed prior to 40 weeks.
Histological processing and pathological evaluation
Upon necropsy, the entire esophagus and jejunum, to a
length approximately 1 cm distal to anastomosis, were
collected and opened longitudinally. Collected tissue
specimens were snap frozen in Tissue-Tek® O.C.T. com-
pound (Sakura® Finetek, Torrance, CA; #4583), sectioned
into 5 μm slides, and stained with hematoxylin and eosin
(H&E). The H&E stained slides were reviewed by two
pathologists to identify areas of normal epithelium (NE),
Barrett’s esophagus (BE), dysplasia, tumor adjacent nor-
mal epithelium (TANE) and esophageal adenocarcinoma
(EAC). Discrepancies in interpretation were resolved by
consensus conference between the 2 pathologists. EAC
was characterized by mucinous, dysplastic glandular cell
growth with atypical nuclei and invasion through the
basement membrane. Dysplasia was characterized by
elongated nuclei; invasive to submucosa and/or muscle.
BE was characterized by the presence of goblet cells in
the mucosa. TANE was characterized by regular mucosa,
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NE, TANE, BE, dysplasia and EAC tumor were macro-
dissected from snap frozen specimens harvested from
the Levrat models and patients for molecular analyses.
Briefly, two tubes of five 40 μm sections were cut in a
cryostat for mRNA and biofilm analysis, respectively.
The areas of interest were dissected using a cold, RNase-
free razor and placed in QIAzol buffer (Qiagen, Valencia,
CA; #79306) for RNA extraction or ATL buffer (Qiagen,
Valencia, CA; #19076) for DNA isolation. The same
number of sections were cut from NE specimens and
placed directly into QIAzol or ATL buffer.
MRNA profiling
RNA was isolated using the miRNeasy Kit (Qiagen,
Valencia, CA; #217004). RNA concentration was spec-
trophotometrically assessed on the SpectraMax M2e
plate reader (Molecular Devices, Sunnyvale, CA) and
RNA quality was assessed by Bioanalyzer (Agilent, Santa
Clara, CA) RIN (RNA Integrity Number) . Four samples
each of NE and TANE, and 5 samples each of BE, dys-
plasia and EAC tumor were selected for mRNA profiling
using the RT2 Profiler Rat Toll-like Receptor Signaling
Pathway Array (SA Bioscience, Frederick, MD; #330231
PARN018Z). Briefly, 500 ng of total RNA was treated for
gDNA contamination then reverse transcribed in a total
volume of 10ul at 42 °C for 15 min. This was followed
by inactivation of reverse transcriptase at 95 °C for
5 min using the RT2 First Strand Kit (Qiagen, Valencia,
CA; #330401) according to manufacturer recommenda-
tions. PCR was performed on cDNA using the
PARN018Z Array and RT2 SYBR Green ROX qPCR
Master Mix (Qiagen, Valencia, CA; #330520). Cycling
parameters for PCR were: 95 °C for 10 min followed by
40 cycles of 95 °C for 15 s, 60 °C for 1 min, 95 °C for
15 s. Dissociation curve analysis cycling parameters
were: 95 °C for 15 s, 60 °C for 1 min, 95 °C for 15 s. Data
was normalized to Ribosomal protein, large, P1 (Rplp1)
and expression calculated by the delta-delta-Ct (2-ΔΔCT)
method [20]. The top differentially expressed mRNAs
were identified using RT2 Profiler PCR Array Data
Analysis v.3.5.
DNA extraction and microbial detection
For DNA extraction, the tissue was placed into a micro-
centrifuge tube (Axygen Scientific,Union City, CA; #
MCT-175-L-C) containing 270 uL of ATL Lysis buffer
(Qiagen, Valencia, CA; #19076) and 30uL proteinase K
(Qiagen, Valencia, CA; #19131). Samples were incubated
at 56 °C until lysis of the tissue was achieved, approxi-
mately 12–36 h. Next 100 μl of a mixture containing 50 μl
each of 0.1 mm and 0.7 mm Zirconia beads (Biospec,
Bartlesville, OK; # 11079101z, 11079107zx respectively)
was added to the samples which were then homogenized
Fig. 1 Study Schema outlining the major steps in the experimental design
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for 10 min at 25 Hz using a Qiagen TissueLyser (Qiagen,
Valencia, CA; #85300) . DNA from the lysed sample was
then extracted using the Qiagen DNeasy Tissue kit
(Qiagen, Valencia, CA; #69506).
For microbial detection, 10 μl of the isolated DNA
sample was loaded per well onto the BAC detection
PCR plate (Abbott Molecular, Des Plains, IL; # PN
05 N13-01). The BAC detection plate is a 96 well plate
which contains 16 primers that survey all bacterial or-
ganisms by using the omnipresent loci (e.g. 16S rRNA
gene sequence); while some are targeted to specific path-
ogens of interest (e.g. the Staphylococcus-specific tufB
gene). The plate also includes primers for the detection
of Candida species and some antibiotic resistance
markers (e.g. mecA, vanA, vanB, and KPC). An internal
calibrator of synthetic DNA template is also included in
each assay, controlling for false negatives (e.g. from PCR
inhibitors) and enabling a semi-quantitative analysis of
the amount of template DNA present. PCR amplification
was carried out and the products were desalted in a
96-well plate and sequentially electro-sprayed into a mass
spectrometer. The spectral signals were processed to de-
termine the identities of the pathogens and their relative
concentrations within the processed tissue [21].
Fluorescent in situ hybridization (FISH)
Aliquots of the tissue specimens were fixed with fresh
4 % paraformaldehyde and incubated for 2–4 h at 4 °C.
After the incubation, the specimen was centrifuged and
the supernatant removed. This process was repeated
twice with Hank’s Salt Saline Solution (HBSS). Next, the
samples were resuspended in 50 % ethanol-PBS solution
and stored at −20 °C for evaluation with FISH. FISH was
performed as described by Nistico et al. (41) using spe-
cies-specific fluorescent 16 s rRNA probes. Escherichia
coli (E. coli) was targeted using probe sequence “GCA
TAA GCG TCG CTG CCG” [22] and Streptococcus pneu-
monia (S. pneumonia) was targeted using “GTG ATG
CAA GTG CAC CTT” [23].
Samples were observed with Confocal Scanning Laser
Microscopy (CSLM) imaging using a Leica DM RXE
microscope attached to a TCS SP2 AOBS confocal
system (Leica Microsystems, Exton, PA) using a 63X
(NA1.2 ) water immersion lens.
Processing of human clinical samples
A total of 32 esophageal and 22 gastric samples were
collected from 28 patients and were snap frozen in
O.C.T. The specimens were sectioned onto 5 μm slides,
stained with hematoxylin and eosin (H&E), and reviewed
by two pathologists, as described earlier, for both micro-
bial detection and FISH. Areas of TANE (3), BE (13),
dysplasia (3) and EAC (5) were identified in the esopha-
geal disease groups while 8 areas of NE were identified
in GERD specimens. Normal gastric epithelium was
identified in 22 gastric specimens from patients inde-
pendent of disease state.
Sample size and statistical analysis
All studies were discovery pilot studies therefore sample
size calculations were not applicable.
Statistical analyses were performed using SPSS software
(IBM, Armonk, NY, Version 20). A p-value < 0.05 was
considered statistically significant. Independent two-tailed
T-tests with two-sample equal variance were used to
compare mean gene expression profiles of TANE, BE,
dysplasia and EAC to NE. For canonical pathway analysis
IPA software was used [24].
Results
Modified Levrat rat model
A total of 37 animals were included in the present study
by undergoing esophagojejunostomy as described above.
Twenty-six rats survived to 40 weeks (29.8 % mortality).
Eleven died (three-died of unknown cause, one-suffered
postoperative anastomotic leak, three-died of respiratory
complications, and four-died of esophageal disease). Of
the 26 rats that survived to 40 weeks, 19 were chosen
for macro dissection based on the presence of TANE (4),
BE (5), dysplasia (5) and EAC (5). All areas were con-
firmed on pathology. Four normal control animals were
also included in order to collect NE (4).
MRNA analysis in the rat model
RT2 Profiler PCR Array Data Analysis v.3.5. identified
TLRs 1-3, 6, 7 and 9 as significantly upregulated in EAC
compared to NE in the rat model. TLR 1 was signifi-
cantly upregulated in BE, dysplasia and TANE. TLR 5
and TLR 6 were significantly down regulated in TANE
(Fig. 2). Thirty one genes involved in the TLR signaling
pathway were significantly dysregulated in EAC, 27 in
dysplasia, 21 in BE (Additional file 1: Figure S1).
Pathway analysis of differentially expressed mRNAs
Ingenuity Pathway Analysis (IPA) revealed an upregula-
tion of the top 10 most significantly dysregulated canon-
ical pathways in EAC with a down regulation of 9 out of
10 pathways in dysplasia (PPARa/RXRa upregulated),
down regulation of the top 10 pathways in BE and down
regulation of 9 out of 10 pathways in TANE (upregulation
of PPAR) (Additional file 2: Figure S2).
Microbial profiling: Levrat model samples
A diverse range of bacterial and fungal organisms were
detected in both the Levrat esophageal specimens and
the human clinical samples using the PCR-ESI-MS-TOF
technology. Microbial profiling of the Levrat rat model
detected microorganisms in all four experimental
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groups. Of the 23 samples tested, 22 Levrat esophageal
specimens were positive for microbial DNA. Forty three
different species of bacteria were detected in the animal
model samples. The most prevalent microorganisms
detected were Aggregatibacter species (8 out of 23),
Escherichia coli (11 out of 23), Haemophilus parain-
fluenzae (6 out of 23), Saccharomyces cerevisiae (15out
of 23), and Streptococcus species (20 out of 23). While
Streptococcus species where evenly distributed between
the experimental groups, some bacteria were more
prevalent within certain groups (Fig. 3). Escherichia coli
was detected in 100 % of the EAC specimens (5 out of 5)
in comparison to 25 % in the NE (1 out of 4), 60 % in the
BE group (3 out of 5) and 40 % in the dysplasia group (2
out of 5). Also of interest Clostridium species was detected
in 40 % of the TANE, dysplasia, and EAC groups but was
absent from the NE and BE specimens. Additionally
Saccharomyces cerevisiae was detected at a higher rate
(80–100 %) within the dysplasia, TANE and BE specimens
than in the NE and EAC (0–20 %).
Microbial profiling: human clinical samples
Microbial profiling of the 54 human clinical samples re-
vealed microorganisms in all five experimental groups.
Of the 54 samples tested, 52were positive for microbial
DNA. The most prevalent microorganisms detected
were Candida sp. (16 out of 54), Gemella sp. (10 out of
54), Haemophilus sp. (12 out of 54), and Streptococcus
sp. (36 out of 54). Streptococcus pneumonia was detected
in high abundance in theGastric NE and BE groups
(50–70 %) in comparison to TANE, dysplasia, and
EAC (20–30 %). Escherichia coli was detected in the
BE and EAC groups but was absent in the TANE, dyspla-
sia, and the NE groups. Actinomyces sp. and Veillonella
parvula were found almost exclusively in the Gastric spec-
imens, while Gemella sp. was found predominantly in the
BE specimens. Additionally Candida albicans and Can-
dida glabrata was detected in more than half of the EAC
samples (Fig. 4). Where tissue was available, we compared
the microbiome of a subjects’ esophageal and gastric
tissue. No correlation was seen within sample location
however correlations within a subject’s specimens were
observed. All 11 subjects with both esophageal and gastric
tissue microbiome results had at least one genus level
correlation between the two locations. Seven subjects had
correlation values of 50 % or greater (Fig. 5).
Fish
To confirm the PCR-ESI-MS-TOF results, where suffi-
cient tissue was available, a secondary method of analysis
Fig. 3 Microbial characterization of rat esophageal tissue using PCR-ESI-MS-TOF technology Bacteria were detected in 2 or more specimens in the
Levrat animal model. Bacteria detected in only one specimen were not included. Each specimen is represented by one column. Rows represent bacterial
species. Cells are color coded for prevalence of the bacteria within the experimental group
Fig. 2 Toll-like receptor expression in TANE, BE, dysplasia and EAC
compared to normal esophageal epithelium (NE). Significant
upregulation of TLRs 1–3, 6, 7 and 9 are observed in EAC
compared to normal epithelium
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was applied. One Levrat rat sample and four human
clinical samples were stained by FISH and visualized by
confocal microscopy (Fig. 6). The FISH probes were
selected based on the species detected by the PCR-ESI-
MS-TOF analysis, specifically Escherichia coli and Strepto-
coccus pneumonia. This probe binds 16 s rRNA. Thus, the
stained bacteria were metabolically active at the time of
fixation and washing. This establishes that PCR-ESI-MS-
TOF is detecting viable bacteria within the tissue at the
time of collection.
Discussion
Gene expression profiling revealed differential expres-
sion of TLRs in the 4 rat tissues of interest compared to
the normal rat epithelium (NE): EAC, dysplasia, BE and
TANE. TLRs 1-3, 6, 7 and 9 are significantly upregulated
in EAC while TLR 1 was significantly upregulated in
TANE, BE and dysplasia. AThis was further corrobo-
rated by incremental dysregulation of a number of genes
as noted in the TLR signaling pathway (21, 27 and 31 for
BE, dysplasia and EAC respectively). Activation of TLRs
along with dysregulation of target genes in this pathway
were confirmed by quantitative RT-PCR and the differ-
ential presence of E. coli and S. cerevisiae across the
EAC spectrum was confirmed by PCR-ESI-MS-TOF and
validated by FISH. These results suggest an active role
for microbial signaling in EAC carcinogenesis using the
Levrat’s model.
TLRs are pattern recognition receptors integral to in-
nate immunity. Their link to tumorigenesis is increas-
ingly being recognized [13]. Expression of TLRs is noted
in various effectors of the immune system as well as
tissues exposed to the external environment, e.g. the
gastrointestinal tract. They can be both extracellular (e.g.
TLR4) to recognize molecules that they may be exposed
to or intracellular (e.g. TLR9) to detect nucleic acids that
would be important in host responses to viruses and
certain bacteria [14–16]. Binding of ligands to TLRs and
signaling can potentially lead to activation of two
pathways involving different adaptor molecules: MyD88-
dependent and MyD88-independent. The MyD88-
dependent pathway leads to production of inflammatory
cytokines, whereas the MyD88-independent pathway is
associated with the stimulation of IFN-β and the matur-
ation of dendritic cells [25]. To date there are 13 different
TLRs recognized and differential expression of these
molecules has been noted on normal esophageal epithe-
lium [26] as well as EAC [27]. Being exposed to pathogens
from the external environment on a daily basis, there is
rationale to explore the potential role of these pathogens
in innate immunity through TLR mediation in EAC [28].
We used the modified Levrat surgical model to study
EAC. The model uses an end-to-side esophagojejunal
anastomosis and is highly efficient for inducing tumori-
genesis with an observed 70 % rate of adenocarcinoma
development at 28 weeks after surgery. Previous studies
using this rat model have shown that the resultant gas-
troduodenojejunal reflux leads to a reliable progression
from BE to EAC on a histologic and molecular level
[29]. This reliable progression from BE to EAC allowed
us to study and identify pathways differentially dysregu-
lated in the metaplasia-dysplasia-carcinoma sequence for
Fig. 4 Microbial characterization of human esophageal tissue using PCR-ESI-MS-TOF technology. Bacteria were detected in 2 or more specimens
in the human clinical samples. Bacteria detected in only one specimen were not included. Each specimen is represented by one column. Rows
represent bacterial species. Cells are color coded for prevalence of the bacteria within the experimental group
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Fig. 5 Comparison of Subject’s samples by location. Microrganisms highlighted in red are genus level match between both the esophageal and
the gastric samples.
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EAC. As noted in Fig. 4, we identified upregulation in the
top 10 most significantly dysregulated canonical pathways
in EAC with a down regulation of 9 out of 10 pathways in
dysplasia (PPARa/RXRa upregulated), down regulation of
the top 10 pathways in BE, and down regulation of 9 out
of 10 pathways in TANE (upregulation of PPAR).
Interestingly, prevalence of E. coli based on PCR-MS-
ESI-TOF analysis was noted in 60 % of cases of BE and
100 % of EAC in the Levrat model, which was validated
by FISH. E.coli infection in the urinary tract has been
shown to cause chronic inflammation, produce histo-
logical changes within host tissue, and promote bladder
lesions within rats. E.coli infection alone produced
elevated levels of IL-6 within bladder tissue similar to
the levels demonstrated in urinary tract inflammatory
diseases and cancer [30]. Elevated IL-6 was also detected
in our Levrat model across the EAC spectrum. Three
mechanisms have been suggested for the role of E .coli
in tumor promotion: (a) the bacteria increase the car-
cinogenic potential of nitrosamine precursors, (b)
accelerate urothelial proliferation, and (c) expose the
host tissue to free radicals which results in DNA
damage. E .coli derived outer membrane vesicles have
been shown to be genotoxic regardless of the strain’s
pathogenicity [31].
In the human clinical samples, esophageal tissue is
continuously exposed to swallowed commensal bacteria
from the oral cavity. Bacteria located within saliva include:
Streptococcus, Neisseria, Veillonella, Fusobacterium, Bac-
teriodes, Lactobacillius, Staphylococcus, and Enterobacteri-
aceae [32]. While normally harmless, several species of
Streptococcus are being investigated in relationship to the
development of esophageal cancer. Streptococcus is an
invasive bacterium which targets host fibronectin and
induces a cytokine response. These actions have the
potential to promote inflammation, cause dysphagia, and
promote carcinogenesis [33]. Our high-level detection
of Streptococcus pneumonia in the NEand BE groups
(50–70 %) in comparison to TANE, dysplasia, and
EAC (20–30 %) hints towards these observations.
Streptococcus may be causing inflammation and dam-
age in the NE and BE groups but once carcinogenesis
has occurred the bacteria leaves the damaged tissue
to invade surrounding healthy tissue.
While several studies have screened esophageal diseases
for microorganisms through the use of culture and
targeted molecular technologies, the application of a
broad technology, PCR-ESI-MS-TOF, allows researchers
to screen specimens without bias. Studying microbiomes
and their potential role in diseases like GERD and EAC
Fig. 6 Biofilm bacteria adherent to rat and human tissues visualized by fluorescence in situ hybridization (FISH) probes (red). Blue is the reflected
light from the tissue. A1-I1 represent FISH and A2-I2 represent the corresponding H&Es. A1,A2) Rat TANE tissue (negative control) shows absence
of E.coli staining within the tissue B1, B2) Rat BE tissue shows presence of E.coli single cells and in clusters attached to the tissue; C1, C2) Rat EAC
tissue shows presence of E. coli single cells and in clusters attached to the tissue; D1,D2) Human TANE tissue (negative control) shows absence of
S. pneumonia staining within the tissue;E1,E2) Human BE tissue shows presence of S. pneumonia single cells and in clusters attached to the tissue;
F1,F2) Human EAC tissue shows presence of S. pneumonia single cells and in clusters attached to the tissue; G1,G2) Human TANE tissue (negative
control) shows absence of E.coli staining within the tissue; H1,H2) Human BE tissue shows presence of E.coli single cells attached to the tissue;
I1,I2) Human EAC tissue shows presence of E.coli single cells and in clusters attached to the tissue. All H&Es are represented at 10X magnification
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opens up a new approach to studying their pathogenesis
and identifying new therapeutic targets [34].
Major limitations of our study include the limited
sample size and focused analysis on the selected group
of microbiota as noted. It would be important to study
in detail other representative groups of microbiomes in
EAC models. Additionally, the pilot study established
the need for a follow on prospective human trial to
delineate the true role of microbiota and TLRs, in both
disease development and progression. As the small sam-
ple size and the cross-sectional design of the current
study are limitations for making strong inferences about
the role of individual microbiomes and TLR associa-
tions, for a heterogenetic cancer. Lastly, our work lays
the foundation for studying the in depth the molecular
mechanisms in play between specific microbiata and
associated TLRs. .
Conclusions
The associations demonstrated between the TLR
signaling pathway and E. coli and S. cerevisiae hint
towards possible early molecular changes being medi-
ated through the microbiome in a rat-model of BE-EAC
sequence. Human clinical samples did corroborate the re-
sults to some extent; however, studies with larger sample
size would be needed to better explore this association.
Additional files
Additional file 1: Figure S1. Venn diagram showing the number of
significantly dysregulated genes in the TLR signaling pathway across the
EAC spectrum. (TIF 511 kb)
Additional file 2: Figure S2. Ingenuity Pathway Analysis (IPA) of the
top ten most significantly dysregulated canonical pathways across the
EAC spectrum. (TIF 659 kb)
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